Motley Fool March 2, 2021
The Fools discuss one of today’s most controversial health companies.
Clover Health (NASDAQ:CLOV) has been one of the most controversial Medicare insurance providers since being brought public by Social Capital and Hedosophia.
In this episode of Industry Focus: Wildcard, Motley Fool contributor Jason Hall and analyst Emily Flippen discuss Clover’s business and its unique value proposition, and then debate whether the controversial short-seller report should have investors running for the door.
Before you consider Clover Health Investments, Corp., you’ll want to hear this.
Investing legends and Motley Fool Co-founders David and Tom Gardner just revealed what they believe are the 10 best stocks for investors to buy right...
Today's Sponsors
Today's Sponsor